Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Parsaclisib HCl

SKU: orb1218518

Description

Parsaclisib HCl is a selectve PI3Kδ inhibitor with antitumor activity. Parsaclisib demonstrates potent activity with IC50 values ranging from 0.2 to 2 nM.

Images & Validation

Key Properties

CAS Number1995889-48-9
MW469.34
Purity>98% (HPLC)
FormulaC20H23Cl2FN6O2
SMILESO=C1NC[C@@H](C2=C(F)C(Cl)=CC([C@@H](N3N=C(C)C4=C(N)N=CN=C43)C)=C2OCC)C1.[H]Cl
TargetPI3K
SolubilityDMSO:90 mg/mL(191.76 mM);Water:Insoluble

Bioactivity

In Vivo
Parsaclisib (10 mg/kg; oral gavage twice daily for 7-19 days) inhibits tumor growth in the BALB/c mice bearing the A20 murine lymphoma cells. Parsaclisib (0.1-10 mg/kg; p.o. twice daily) slows Pfeiffer xenograft tumor growth in a dose-dependent manner. And Parsaclisib was well tolerated. Parsaclisib (0.5-1 mg/kg; a single p.o.) inhibits pAKT (Ser473) in Pfeiffer subcutaneous mouse xenograft models. Animal model: Female BALB/c mice (5-9 weeks) were inoculated with A20 cells. Dosage: 10 mg/kg. Administration: Oral gavage twice daily for 7-19 days. Result: Resulted in significant tumor growth inhibition (TGI). Reduced the percentage of Tregs (CD4+CD25+FOXP3+) in tumors and spleens. Increased the ratio of CD4+ and CD8+ T cells to Tregs in spleens and tumors. Decreased the number of CD4+CD44 high and CD8+CD44 high T cells in both spleens and tumors.
In Vitro
Parsaclisib (0.1-3000 nM; 4 d) inhibits proliferation of MCL and DLBCL cell lines. Parsaclisib (0.1-1000 nM; 2 h) inhibits anti-IgM-induced pAKT (Ser473) in the Ramos Burkitt’s lymphoma cell line, with an IC50 of 1 nM. Parsaclisib inhibits the proliferation of human, dog, rat, and mouse primary B cells after activation of these receptors, with IC50s ranging from 0.2 to 1.7 nM. Cell Proliferation Assay Cell line: Jeko-1, Mino, JVM2, Rec-1, Pfeiffer, SU-DHL-5, SU-DHL-6, WSU-NHL, SU-DHL-4, SU-DHL-8, and WILL-2 cells. Concentration: 0.1-3000 nM Incubation time: 4 days. Result: Resulted in a maximal inhibition of 70-90%, with IC50s of ≤10 nM in the four MCL cell lines. Pfeiffer, SU-DHL-5, SU-DHL-6, and WSU-NHL were highly sensitive, with IC50s from 2 to 8 nM.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

INCB50465 HCl | INCB-50465 | INCB 50465 | INCB050465 HCl | INCB-050465 | INCB 050465

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

500 mg
200 mg
5 mg
$ 510.00
50 mg
$ 2,470.00
100 mg
$ 3,940.00